ST. PETERSBURG, Fla., Dec. 21, 2015 /PRNewswire/ -- Kevin Harrington, one of the original Sharks from hit reality series Shark Tank, and the Product Managers of AsSeenOnTV.pro are pleased to announce the launch of a new DRTV campaign with Omiera Labs.
As a multi-active topical drug delivery expert, Omiera Labs is offering a new line of nonprescription topical products that address a variety of healthcare areas, including orthopedics, podiatry, dermatology, and more. Glocione, for example, dramatically reduces the appearance of wrinkles, fine lines, and age spots, moisturizing and refurbishing the skin to encourage and preserve suppleness.
Specially formulated by a team of pharmacists and physicians and tested by dermatologists, Glocione is a potent blend of glutathione and other antioxidants, peptides, alpha hydroxyl acids, hyaluronic acid, and collagen. When used twice daily, the fast-acting formula brightens sun-damaged skin, firms up sagging skin, moisturizes, smoothes out lines, and protects against UV rays that cause color and pigment changes and wrinkles. Users report seeing positive results within 4-6 days.
"We are really excited to be launching our campaign and working with a DRTV veteran like Kevin Harrington," said Omiera Labs Founder and CEO, Amro Amer. "Kevin will help us greatly in making more consumers aware of our unique product offerings."
Amer is a licensed pharmacist, holding membership in a number of professional organizations including the Professional Compounding Centers of America, the International Journal of Pharmaceutical Compounding, the American Academy of Anti-Aging Medicine, the National Association of Sports Nutrition, the American Academy of Pain Management, and the Society of Cosmetic Chemists. Amer founded Omiera Labs in 2000 to provide practical, evidence-based, reasonably priced, over-the-counter formulas that improve the quality of life for individuals dealing with a variety of health issues. All products are backed by a 100% money-back guarantee.
As part of its DRTV campaign with AsSeenOnTV.pro, Omiera Labs will be appearing in 30 and 60 second spots airing nationwide and featuring the original Shark himself, Kevin Harrington. AsSeenOnTV.pro is comprised of an award-winning team of producers, writers, videographers, and editors as well as industry veterans dedicated to finding the latest, most innovative products and ideas, and putting them on the DRTV map.
About Kevin Harrington
As the inventor of the infomercial, founder of As Seen on TV, and one of the original Sharks on Shark Tank, Kevin Harrington has worked with some of the world's biggest celebrities and launched some of the best-selling DRTV campaigns in history. Since producing his first 30-minute infomercial in 1984, Harrington has been involved in over 500 product launches that have resulted in over $4 billion in sales. Now, in his latest venture with AsSeenOnTV.pro, Harrington is on the hunt for the best new products and ideas, bringing them to homes everywhere through personalized DRTV campaigns featuring the Shark.
Headquartered in Florida, AsSeenOnTV.pro is a full-service production, branding, and marketing company that specializes in direct response television, short- and long-form commercials, and brand building. Based out of a 25,000+ sq ft, state-of-the-art studio, the company's creative team handles every aspect of production from script to screen to airing. For nearly two decades, AsSeenOnTV.pro's veteran staff of writers, producers, videographers, and editors has amassed more than 50 Telly Awards, thousands of prestigious clients, and over $20 million in television placements.
For more information on Omiera Labs and Glocione, please visit www.omieralabs.com.
To view the company's 60 second spot with AsSeenOnTV.pro and Kevin Harrington, please visit this site.
Media Contact: Public Relations, AsSeenOnTV.pro, 813-400-1515, email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kevin-harrington-and-asseenontvpro-put-the-spotlight-on-omiera-labs-and-glocione-300195699.html
SOURCE Omiera Labs